Development, Validation and Application of Advanced Biomarkers in Cerebral Tumours
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Biomarkers".
Deadline for manuscript submissions: 30 September 2025 | Viewed by 1193
Special Issue Editor
Special Issue Information
Dear Colleagues,
Over the past 20 years the concept of the biomarker has become intrinsic to medical research. The identification of individual quantifiable features, related to tumour biology, tumour behaviour, prognosis and treatment response has been one of the largest areas of original research. Following the discovery of potentially novel biomarkers extensive research is needed to confirm their potential validity, validate their reproducibility and optimal methodology for measurement and to then explore and confirm their potential biological meaning. Biomarkers may be based on chemical, genetic or biological features, may be extracted from data such as liquid biopsy, genome and gene expression data, imaging data, mass spectroscopy, proteomics or metabolomics. Whatever the methodology for individual biomarkers they must be robust, reproducible and provide valuable information concerning tumour biology, behaviour, prognosis, treatment response or some other aspect of tumour behaviour.
This Special Issue invites submissions related to the discovery, validation and application of novel biomarkers for the study and clinical management of intra-cerebral tumours. The editorial team will consider applications relating to discovery of potential biomarkers, validation studies of existing biomarkers and studies providing clinical validation or evidence of application of relatively novel biomarkers.
We will also consider applications that describe novel data classification or artificial intelligence applications, which might optimise the use and application of existing biomarkers.
Prof. Dr. Alan Jackson
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
